Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biote (BTMD) Cash from Operations (2021 - 2025)

Biote (BTMD) has 5 years of Cash from Operations data on record, last reported at 14072000.0 in Q3 2025.

  • For Q3 2025, Cash from Operations fell 9.54% year-over-year to 14072000.0; the TTM value through Sep 2025 reached 39993000.0, changed 0.41%, while the annual FY2024 figure was 45243000.0, 68.3% up from the prior year.
  • Cash from Operations reached 14072000.0 in Q3 2025 per BTMD's latest filing, up from 7086000.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 17944996.0 in Q2 2021 and bottomed at 28570000.0 in Q2 2022.
  • Average Cash from Operations over 5 years is 6542842.11, with a median of 6969000.0 recorded in 2022.
  • Peak YoY movement for Cash from Operations: crashed 259.21% in 2022, then skyrocketed 9622.5% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 10080000.0 in 2021, then tumbled by 39.97% to 6051000.0 in 2022, then rose by 14.96% to 6956000.0 in 2023, then surged by 77.8% to 12368000.0 in 2024, then rose by 13.78% to 14072000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash from Operations were 14072000.0 in Q3 2025, 7086000.0 in Q2 2025, and 6467000.0 in Q1 2025.